(Q48165678)

9 February 2018

title

Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease. (English)

1 reference

9 February 2018

1 reference

1 reference

1 reference

2

1 reference

9 February 2018

Yves Agid

6

object named as

Agid Y

1 reference

9 February 2018

Muriel MP

1

1 reference

9 February 2018

Levey AI

3

1 reference

9 February 2018

Laribi O

4

1 reference

9 February 2018

Abrous DN

5

1 reference

9 February 2018

Bloch B

7

1 reference

9 February 2018

Hirsch EC

8

1 reference

9 February 2018

publication date

1 July 1999

1 reference

9 February 2018

published in

Annals of Neurology

1 reference

9 February 2018

volume

46

1 reference

9 February 2018

page(s)

103-111

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

Parkinsons disease and its chemotherapy

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

Subcutaneous lisuride infusion in Parkinson's disease. Response to chronic administration in 34 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

Ontogeny of the striatal neurons expressing the D2 dopamine receptor in humans: an in situ hybridization and receptor-binding study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

Ontogeny of the striatal neurons expressing the D1 dopamine receptor in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

D1 and D2 dopamine receptors in perinatal and adult basal ganglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

Dopamine D2 receptor density remains constant in treated Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

Dopamine-stimulated adenylate cyclase activity in the human brain: Changes in Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

Dopamine D-1 receptors in the parkinsonian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

Differential expression of D1 and D2 dopamine and m4 muscarinic acetylcholine receptor proteins in identified striatonigral neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

Ultrastructural localization of D1 dopamine receptor immunoreactivity in rat striatonigral neurons and its relation with dopaminergic innervation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

Repeated Levodopa Infusions in Fluctuating Parkinsonʼs Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

Dopamine receptor mRNA expression in human striatum and neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

Ontogeny of the D1 Dopamine Receptor in the Rat Striatonigral System: an lmmunohistochemical Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

Expression of glutamate receptors in the human and rat basal ganglia: Effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in parkinson's disease and rat with 6-OHDA lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

Dyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199907%2946%3A1%3C103%3A%3AAID-ANA15%3E3.0.CO%3B2-Z

10.1002/1531-8249(199907)46:1<103::AID-ANA15>3.0.CO;2-Z

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

10401786

1 reference

9 February 2018